Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

MRIGlobal, Evogen collaborate on molecular diagnostics
September 2013
SHARING OPTIONS:

KANSAS CITY, Mo.A strategic collaboration was struck in late July between MRIGlobal and Evogen Inc. for the development of advanced molecular diagnostics products, specifically ones targeted for the in-vitro and clinical molecular diagnostics markets. The agreement is slated to run for five years, and under the terms, MRIGlobal will provide Evogen with product development services including assay development, technology transfer, analytical and clinical studies and commercialization support. Financial terms were not disclosed.
 
"We envision a partnership built on an already strong foundation of our earlier work together," Dr. Thomas M. Sack, MRIGlobal's interim president and CEO, said in a press release. "Evogen and MRIGlobal see opportunities to collaborate on delivering new and innovative solutions that can help physicians make earlier and more accurate diagnoses."

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.